Skip to Content Skip to Footer
David Q. Pham, PharmD, BCPS, CDCES, BC-ADM, APH

David Q. Pham, PharmD, BCPS, CDCES, BC-ADM, APH

Associate Professor of Pharmacy Practice and Administration

College of Pharmacy

dqpham@westernu.edu

Phone: 909-706-3522

Join year: August, 2007

  • Education

    PharmD 2001
    University of the Pacific

  • Education Experience

    Residency

    Pharmacy Practice 2001-2002
    St. Joseph's Medical Center

  • Certification

    Advanced Practice Pharmacist (APh)
    2024 California State Board of Pharmacy

    Board Certified-Advanced Diabetes Management (BC-ADM)
    2016 American Association of Diabetes Educators

    Certified Diabetes Care and Education Specialist (CDCES)
    2012 Certification Board for Diabetes Care and Education

    Board Certified Pharmacotherapy Specialist (BCPS)
    2005 Board of Pharmaceutical Specialties

  • Professional Experience

    His interests include teaching, scholarship, and service to both the College of Pharmacy as well as the community.

  • Work Site

    Mary & Dick Allen Diabetes Center
    Hoag Hospital
    520 Superior Ave., Suite 150
    Newport Beach, CA 92663

    This ambulatory care rotation allows third and fourth year Pharm.D. candidates to assist in the care and education of patients with diabetes mellitus at the Mary & Dick Allen Diabetes Center at Hoag Hospital.

  • Teaching Experience

    He has been a member of the pharmacy faculty since August 2002.

  • Organizations

    Dr. Pham is very active in pharmacy organizations both at the local and state level.

  • Publications

    Andraos J, SmithSR, TranA, Pham DQ.Narrative review of data supporting alternate first-line therapies over metformin in type 2 diabetes. J Diabetes Metab Disord 2024. https://doi.org/10.1007/s40200-024-01406-6

    Pham DQ, Thorsell A, Castorino K, Cobb B. A review of CONCEPTT study findings including subanalyses in pregnant women using continuous glucose monitoring with type 1 diabetes and their offspring. Endocr Connect 2024 Jan 11;13(2):e230407. Doi:10.1530/EC-23-0407. PMID: 38010170;PMCID: PMC10831538.

    Davies ML, Pham DQ, Drab SR. GLP1-RA add-on therapy with type 2 diabetes currently on a bolus containing insulin regimen. Pharmacotherapy 2016;36:893-905.

    Kugler AJ, Fabbio KL, Pham DQ. Inhaled technosphere insulin: a novel delivery system and formulation for the treatment of types 1 and 2 diabetes mellitus. Pharmacotherapy 2015;35:298-314.

    Pham DQ, Iyer KV, Woodring H, Vuu R, McArthur L. Insulin pump therapy and continuous glucose monitoring. Pharmacy Times 2011;77(2):38-40.

    Pham DQ, Nogid A, Plakogiannis R. Sitagliptin: a novel agent for the management of type 2 diabetes mellitus. American Journal of Health-System Pharmacy 2008;65:521-31.

    Pham DQ, Cohen H, Chu V. Inhaled human [rDNA origin] insulin, a novel formulation for diabetes mellitus. Journal of Clinical Pharmacology 2007;47:890-903.

    Pham AQ, Kourlas H, Pham DQ. Cinnamon supplementation in type 2 diabetes mellitus. Pharmacotherapy 2007;27:595-9.

    Goldberg T, Pham DQ. New pharmacotherapeutic approaches for diabetes mellitus. Pharmacy Times 2007;73(7):68-75.

    Pham AQ, Pham DQ. Monitor your blood sugar to stay healthy. Pharmacy Times 2007;73(3):48-9.

    Nogid A, Pham DQ. Adjunctive therapy with pramlintide in patients with type 1 or type 2 diabetes mellitus. Pharmacotherapy 2006;26:1626-40.